Quarterly report · Q2

Period2023-01-01 → 2023-06-30
Filed2023-08-08
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥501m2023-01-01 → 2023-06-30Cons.Net sales
Revenue¥1.4bn2022-01-01 → 2022-12-31Cons.Net sales (5-year summary)
Revenue¥840m2022-01-01 → 2022-06-30Cons.Net sales
Operating income−¥864m2023-01-01 → 2023-06-30Cons.Operating income
Operating income−¥312m2022-01-01 → 2022-06-30Cons.Operating income
Ordinary income−¥868m2023-01-01 → 2023-06-30Cons.Ordinary income
Ordinary income−¥1.3bn2022-01-01 → 2022-12-31Cons.Ordinary income loss (5-year summary)
Ordinary income−¥306m2022-01-01 → 2022-06-30Cons.Ordinary income
Profit before tax−¥869m2023-01-01 → 2023-06-30Cons.Income before income taxes
Profit before tax−¥349m2022-01-01 → 2022-06-30Cons.Income before income taxes
Net income (owners)−¥886m2023-01-01 → 2023-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)−¥1.3bn2022-01-01 → 2022-12-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥359m2022-01-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income−¥886m2023-01-01 → 2023-06-30Cons.Profit loss
Net income−¥359m2022-01-01 → 2022-06-30Cons.Profit loss
Total assets¥4.6bnat 2023-06-30Cons.Assets
Total assets¥4.3bnat 2022-12-31Cons.Assets
Total assets¥5.2bnat 2022-06-30Cons.Total assets (5-year summary)
Total liabilities¥453mat 2023-06-30Cons.Liabilities
Total liabilities¥625mat 2022-12-31Cons.Liabilities
Net assets / equity¥4.1bnat 2023-06-30Cons.Net assets
Net assets / equity¥3.6bnat 2022-12-31Cons.Net assets
Net assets / equity¥4.4bnat 2022-06-30Cons.Net assets (5-year summary)
Cash and deposits¥3.7bnat 2023-06-30Cons.Cash and deposits
Cash and deposits¥3.4bnat 2022-12-31Cons.Cash and deposits
Cash & equivalents¥3.7bnat 2023-06-30Cons.Cash and cash equivalents
Cash & equivalents¥3.4bnat 2022-12-31Cons.Cash and cash equivalents
Cash & equivalents¥4.7bnat 2022-06-30Cons.Cash and cash equivalents
Cash & equivalents¥3.8bnat 2021-12-31dCons.Cash and cash equivalents
Operating cash flow−¥939m2023-01-01 → 2023-06-30Cons.Net cash provided by used in operating activities
Operating cash flow−¥708m2022-01-01 → 2022-12-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥585m2022-01-01 → 2022-06-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥7m2023-01-01 → 2023-06-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥126m2022-01-01 → 2022-12-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥57m2022-01-01 → 2022-06-30Cons.Net cash provided by used in investment activities
Financing cash flow¥1.2bn2023-01-01 → 2023-06-30Cons.Net cash provided by used in financing activities
Financing cash flow¥367m2022-01-01 → 2022-12-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥166m2022-01-01 → 2022-06-30Cons.Net cash provided by used in financing activities
EPS (basic)¥-53.812023-01-01 → 2023-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-21.462023-04-01 → 2023-06-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-99.12022-01-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-26.532022-01-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-25.252022-04-01 → 2022-06-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio89.9%at 2023-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio85.0%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio84.7%at 2022-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 10
SegmentItemPeriodValue
jpcrp040300-q2r_E00987-000Drug Discovery Businessreportable segmentsegment profit2023-01-01 → 2023-06-30−¥1.0bn
jpcrp040300-q2r_E00987-000Drug Discovery Support Businessreportable segmentrevenue2023-01-01 → 2023-06-30¥501m
jpcrp040300-q2r_E00987-000Drug Discovery Support Businessreportable segmentrevenue external2023-01-01 → 2023-06-30¥501m
jpcrp040300-q2r_E00987-000Drug Discovery Support Businessreportable segmentsegment profit2023-01-01 → 2023-06-30¥169m
jpcrp040300-q2r_E00987-000Drug Discovery Businessreportable segmentrevenue2022-01-01 → 2022-06-30¥286m
jpcrp040300-q2r_E00987-000Drug Discovery Businessreportable segmentrevenue external2022-01-01 → 2022-06-30¥286m
jpcrp040300-q2r_E00987-000Drug Discovery Businessreportable segmentsegment profit2022-01-01 → 2022-06-30−¥547m
jpcrp040300-q2r_E00987-000Drug Discovery Support Businessreportable segmentrevenue2022-01-01 → 2022-06-30¥553m
jpcrp040300-q2r_E00987-000Drug Discovery Support Businessreportable segmentrevenue external2022-01-01 → 2022-06-30¥553m
jpcrp040300-q2r_E00987-000Drug Discovery Support Businessreportable segmentsegment profit2022-01-01 → 2022-06-30¥235m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 424
ItemContextValueUnit
Other caPrior1YearInstant424308000JPY
Other caCurrentQuarterInstant388436000JPY
Current assetsPrior1YearInstant4104316000JPY
Current assetsCurrentQuarterInstant4407673000JPY
Property plant and equipmentPrior1YearInstant100231000JPY
Property plant and equipmentCurrentQuarterInstant90577000JPY
Intangible assetsPrior1YearInstant1915000JPY
Intangible assetsCurrentQuarterInstant1503000JPY
Investments and other assetsPrior1YearInstant59990000JPY
Investments and other assetsCurrentQuarterInstant65363000JPY
Noncurrent assetsPrior1YearInstant162137000JPY
Noncurrent assetsCurrentQuarterInstant157444000JPY
AssetsPrior1YearInstant4266453000JPY
AssetsCurrentQuarterInstant4565118000JPY
Accounts payable tradePrior1YearInstant1962000JPY
Accounts payable tradeCurrentQuarterInstant-JPY
Current portion of bondsPrior1YearInstant32000000JPY
Current portion of bondsCurrentQuarterInstant18000000JPY
Current portion of long term loans payablePrior1YearInstant119988000JPY
Current portion of long term loans payableCurrentQuarterInstant119988000JPY
Accounts payable otherPrior1YearInstant235136000JPY
Accounts payable otherCurrentQuarterInstant137227000JPY
Income taxes payablePrior1YearInstant30664000JPY
Income taxes payableCurrentQuarterInstant31098000JPY
Other clPrior1YearInstant16654000JPY
Other clCurrentQuarterInstant18814000JPY
Current liabilitiesPrior1YearInstant436407000JPY
Current liabilitiesCurrentQuarterInstant325128000JPY
Long term loans payablePrior1YearInstant148402000JPY
Long term loans payableCurrentQuarterInstant88408000JPY
Asset retirement obligations nclPrior1YearInstant38040000JPY
Asset retirement obligations nclCurrentQuarterInstant38349000JPY
Other nclPrior1YearInstant1759000JPY
Other nclCurrentQuarterInstant1431000JPY
Noncurrent liabilitiesPrior1YearInstant188201000JPY
Noncurrent liabilitiesCurrentQuarterInstant128188000JPY
LiabilitiesPrior1YearInstant624609000JPY
LiabilitiesCurrentQuarterInstant453317000JPY
Capital stockPrior1YearInstant1382246000JPY
Capital stockCurrentQuarterInstant2052614000JPY
Capital surplusPrior1YearInstant5133456000JPY
Capital surplusCurrentQuarterInstant5803823000JPY
Retained earningsPrior1YearInstant-2922490000JPY
Retained earningsCurrentQuarterInstant-3808099000JPY
Treasury stockPrior1YearInstant-222000JPY
Treasury stockCurrentQuarterInstant-222000JPY
Shareholders equityPrior1YearInstant3592988000JPY
Shareholders equityCurrentQuarterInstant4048115000JPY
Valuation difference on available for sale securitiesPrior1YearInstant-2373000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant-2713000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-12-31pass
balance sheet identityconsolidated 2023-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net assetsconsolidated 2023-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-06-30pass
statement vs summary · operating cash flowconsolidated 2022-01-01/2022-06-30pass
statement vs summary · operating cash flowconsolidated 2023-01-01/2023-06-30pass
statement vs summary · revenueconsolidated 2022-01-01/2022-06-30pass
statement vs summary · revenueconsolidated 2023-01-01/2023-06-30pass
statement vs summary · total assetsconsolidated 2022-12-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass